Drug intelligence / Profile preview

Zigfol-Plus

Development stage
Unknown
Lead developer
Juvenor Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Zigfol-Plus is a combination nutritional supplement marketed by Juvenor Pharma, primarily used in the management of vitamin deficiencies, anemia, and neurological health. It typically contains a combination of **Methylcobalamin** (a form of Vitamin B12), **Folic Acid** (Vitamin B9), and **Pyridoxine Hydrochloride** (Vitamin B6). These components serve as essential cofactors in various metabolic processes, including DNA synthesis, the maturation of red blood cells, and the maintenance of the myelin sheath in the nervous system. Zigfol-Plus is commonly prescribed for conditions such as peripheral neuropathy, megaloblastic anemia, and as a prenatal supplement to prevent neural tube defects during pregnancy.

Brand names
Zigfol-Plus
02

Targets

DNAMTR (Methionine synthase)

Beyond the preview

Go deeper on Zigfol-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zigfol-Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call